Syllabus · Historical · V4 (2023) · Endocrine System
U2 · Endocrine Pharmacology
U2.iii · Endocrine Pharmacology
Understand the pharmacology of oral hypoglycaemic drugs.
Written examination
SAQ history
Oral Hypoglycaemics — Classification & Mechanisms
2 exam appearances
Classify the oral hypoglycaemic drugs (20% marks); include their mechanism of action (40% marks) and their most significant side effects (40% marks).
37%
Classify the oral hypoglycaemic drugs; include their mechanism of action, and their most significant side effects.
—
Oral Hypoglycaemics — Selected Classes
1 exam appearance
Outline the mechanisms of action and adverse effects of the following: (a) Biguanides (35% of marks). (b) Sodium-Glucose cotransporter – 2 (SGLT-2) inhibitors (SGLT-2) (35% of marks). (c) Sulfonylureas (30% of marks).
52%
Oral examination
VIVA history
-
2011A · VIVA 6
This Viva will examine your knowledge of the physiology of glucose regulation and hypoglycaemic drugs as well as the physiology of the Thyroid gland Q 1. Describe the physiology of Insulin This viva began with a discussion on the physiology of insulin, physiological consequences of insulin deficiency, oral hypoglycaemic drugs and the thyroid gland. Generally candidates performed well in this viva. The role of insulin beyond metabolism of glucose, fat and protein was not well understood. The differences in the pharmacology between T4 and T3 was another area of weakness.
Sources: objective text from the relevant CICM syllabus; historical SAQ and VIVA wording from CICM examiner reports.